Volume 24, Number 8—August 2018
Research
Novel Enterobacter Lineage as Leading Cause of Nosocomial Outbreak Involving Carbapenemase-Producing Strains
Table 1
Characteristic | Patient no. |
||||||
---|---|---|---|---|---|---|---|
P1 | P2 | P3 | P4 | P5 | P6 | P7 | |
Patient age, y/sex |
67/F |
72/M |
64/F |
69/M |
87/M |
84/F |
82/M |
Hospitalization duration | 10 d | 106 d | 52 d | 26 d | 6 d | 69 d | 36 d |
Purpose of hospitalization | Kidney transplant | Peripheral arterial disease | Septic shock | Kidney transplant | Consciousness disorder | Necrotic purpura | Vesical lithotrity |
Type of ward |
Transplant, medicine |
Surgery, medical, ICU |
Medical, ICU |
Transplant, medical |
Medical, ICU |
Medical |
Surgery, medical, ICU |
Antimicrobial therapy before diagnosis† |
VAN, OFL, AMX |
PTZ, VAN, AMI, MEM,† CTR |
CTR, VAN, TZP, MET, AMI, CLI, IMP† |
AMX, VAN |
AMC |
CTR, GEN |
CTX, OFL, AMX, PTZ, GEN |
Urinary catheter | Yes | Yes | Yes | Yes | Yes | No | Yes |
Intubation | No | Yes | Yes | No | No | No | No |
Central venous catheter |
Yes |
Yes |
Yes |
Yes |
No |
No |
No |
In-hospital death: delay from admission, d, and etiology |
No |
Yes: 106, septic shock from respiratory system |
Yes: 52, septic shock, undetermined origin |
No |
No |
No |
Yes: 36, septic shock, peritonitis with hemorrhage |
Last negative sample;‡ delay from admission, d |
Urinary; 7 |
Urinary; 61 |
Urinary; 1 |
Urinary; 20 |
Rectal swab; 2 |
Necrotic skin; 39 |
Urinary; 2 |
First positive sample | Urinary | Urinary | Urinary | Urinary | Urinary | Necrotic Skin | Peritoneal fluid |
Delay from admission, d | 32 | 76 | 41 | 29 | 20 | 49 | 28 |
Delay from last negative sample, d |
25 |
15 |
40 |
9 |
18 |
10 |
26 |
ST | ST873 | ST873 | ST118 | ST873 | ST118 | ST873 | ST110 |
Isolate identification | C45 | C46 | C47 | C48 | C308 | C310 | C309 |
*AMI, amikacin; AMX, amoxicillin; AMC, amoxicillin-clavulanate; CLI, clindamycin; CTR, ceftriaxone; CTX, cefotaxime; GEN, gentamicin; ICU, intensive care unit; ICU, intensive care unit; IMP, imipenem; MET, metronidazole; MEM, meropenem; OFL, ofloxacin; PTZ, piperacillin/tazobactam; ST, sequence type; VAN, vancomycin.
†Carbapenems.
‡For detection of VIM-4–producing Enterobacter cloacae complex.
1These authors contributed equally to this article.
Page created: July 18, 2018
Page updated: July 18, 2018
Page reviewed: July 18, 2018
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.